Psychosis medical therapy

Jump to navigation Jump to search

Psychosis Microchapters


Patient Information


Historical Perspective




Differentiating Psychosis from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


History and Symptoms

Physical Examination

Laboratory Findings


Other Diagnostic Studies


Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Psychosis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Psychosis medical therapy

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Psychosis medical therapy

CDC on Psychosis medical therapy

Psychosis medical therapy in the news

Blogs on Psychosis medical therapy

Directions to Hospitals Treating Psychosis

Risk calculators and risk factors for Psychosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Medical Therapy

The treatment of psychosis often depends on what associated diagnosis (such as schizophrenia or bipolar disorder) is thought to be present. However, the first line treatment for psychotic symptoms is usually a neuroleptic (also termed 'antipsychotic') medication, and in some cases hospitalisation. There is growing evidence that cognitive behavior therapy[1] and family therapy[2] can be effective in managing psychotic symptoms. When other treatments for psychosis are ineffective, electroconvulsive therapy (ECT) (aka shock treatment) is sometimes utilized to relieve the underlying symptoms of psychosis, such as depression or schizophrenia. There is also increasing research suggesting that Animal-Assisted Therapy can contribute to the improvement in general well-being of people with schizophrenia.[3]


  1. Birchwood, M (2006). "The future of cognitive-behavioural therapy for psychosis: not a quasi-neuroleptic". British Journal of Psychiatry. 188: 108–108. PMID 16449695. Unknown parameter |coauthors= ignored (help); |access-date= requires |url= (help)
  2. Haddock, G (2005). "Psychological interventions in early psychosis". Schizophrenia Bulletin. 31 (3): 697–704. PMID 16006594. Unknown parameter |coauthors= ignored (help); |access-date= requires |url= (help)
  3. Nathans-Barel, I. (2005). "Animal-assisted therapy ameliorates anhedonia in schizophrenia patients". Psychotherapy and Psychosomatics. 74 (1): 31–35. Unknown parameter |coauthors= ignored (help)

Template:WH Template:WS